Oramed Pharmaceuticals Inc (ORMP) — Capital Reinvestment Ratio
Latest as of June 2024:
0.00x
Oramed Pharmaceuticals Inc (ORMP) has a Capital Reinvestment Ratio of 0.00x as of June 2024, meaning it reinvests 0% of its operating cash flow ($2.07 Million) in capital expenditures ($17.06). See cash generation quality of Oramed Pharmaceuticals Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$2.07 Million
USD
Capital Expenditures
$17.06
USD
Data as of
Jun 2024
Most recent filing
Oramed Pharmaceuticals Inc Capital Reinvestment Ratio (2016–2016)
This chart tracks Oramed Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Oramed Pharmaceuticals Inc (2016–2016)
Year-by-year Capital Reinvestment Ratio for Oramed Pharmaceuticals Inc from 2016 to 2016. For live market cap and broader valuation context, see ORMP stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.00x | $4.66 Million | $9.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow